| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 4 |
| 1 | DOCETAXEL | 3 |
| 2 | DOCETAXEL ANHYDROUS | 3 |
| 3 | BICALUTAMIDE | 2 |
| 4 | CARBOPLATIN | 2 |
| 5 | ENZALUTAMIDE | 2 |
| 6 | ABIRATERONE ACETATE | 1 |
| 7 | ALISKIREN | 1 |
| 8 | ALISKIREN HEMIFUMARATE | 1 |
| 9 | AMLODIPINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0025 |
| 1 | CABAZITAXEL | 1 | 0.0004 |
| 2 | ALISKIREN HEMIFUMARATE | 1 | 0.0002 |
| 3 | BICALUTAMIDE | 2 | 0.0002 |
| 4 | TERAZOSIN HYDROCHLORIDE | 1 | 0.0001 |
| 5 | EVEROLIMUS TABLETS | 1 | 0.0001 |
| 6 | LEUPROLIDE ACETATE | 4 | 0.0001 |
| 7 | DOCETAXEL ANHYDROUS | 3 | 0.0001 |
| 8 | ENZALUTAMIDE | 2 | 0.0000 |
| 9 | ABIRATERONE ACETATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen Receptor Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Microtubule Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 4 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 6 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 7 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 8 | Osmotic Laxative [EPC] | 1 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 2 | 0.0000 |